FTC Staff Comment Before the Food and Drug Administration Regarding the Current Use of Human Drug and Biological Products Labeled As Homeopathic, and the FDA's Regulatory Framework For Such Products
Date
Matter Number
P114505
Docket Number
80 Fed. Reg. 16327 (Mar. 27, 2015)
FTC staff has recommended that the U.S. Food and Drug Administration (FDA) reconsider the framework it uses to regulate homeopathic medications because it may appear to conflict with the FTC’s...
File
Exhibit A
(1.61 MB)
File
Exhibit B-Part 1
(2.51 MB)
File
Exhibit B-Part 2
(3.34 MB)
File
Exhibit C
(5.08 MB)